Abstract

ObjectiveA potential association between diabetes and Guillain-Barré syndrome (GBS) has been indicated by a few case studies. We retrospectively analyzed the clinical features of a large cohort of GBS patients to explore the relationship between the level of fasting plasma glucose (FPG) obtained in the acute phase at admission and the severity of GBS.MethodsThree hundred and four GBS patients were divided into two groups, one with normal FPG and the other with high FPG levels according to the international standards of FPG.ResultsThe GBS disability scale score was positively, the Medical Research Council (MRC) sum score was negatively correlated to the level of FPG, but not to blood HBA1c or CSF glucose concentrations. A relatively higher FPG level was observed in older and younger GBS patients, and more often in those with cranial nerve involvement, autonomic deficit, dyspnea and ventilator dependence than in patients without these clinical characteristics. Importantly, higher levels of FPG at admission were associated with poorer short-term prognosis measured by the MRC sum score and the GBS disability scale at discharge.ConclusionsOur data demonstrates that FPG in the acute phase of GBS correlates with the severity of GBS and may predict the short-term prognosis of GBS.

Highlights

  • Findings from several preliminary studies have indicated a potential association between blood glucose levels and Guillain-Barré syndrome (GBS) [1,2,3,4]

  • The GBS disability scale score was positively, the Medical Research Council (MRC) sum score was negatively correlated to the level of fasting plasma glucose (FPG), but not to blood HBA1c or CSF glucose concentrations

  • Higher levels of FPG at admission were associated with poorer short-term prognosis measured by the MRC sum score and the GBS disability scale at discharge

Read more

Summary

Introduction

Findings from several preliminary studies have indicated a potential association between blood glucose levels and Guillain-Barré syndrome (GBS) [1,2,3,4]. Gangliosides are expressed in both the peripheral nervous system (the node of Ranvier and axolemma) and the islets, and auto-antibodies to gangliosides appear in both GBS and type 1 diabetes as well [4]. Accumulated evidence implies a potential association between GBS and diabetes [1,2,3,4], this relationship has not been explored systematically in a large cohort of patients.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call